Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 293150, 5 pages
http://dx.doi.org/10.1155/2013/293150
Case Report

Biclonal IgD and IgM Plasma Cell Myeloma: A Report of Two Cases and a Literature Review

1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada M5S 1A1
2Pathology Laboratory, Patras General Hospital “O Agios Andreas,” 26500 Patras, Greece
3Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA
4The Institute for Transfusion Medicine, Pittsburgh, PA 15213, USA
5Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA

Received 16 August 2013; Accepted 17 September 2013

Academic Editors: R. Herrmann, K. Konstantopoulos, A. Ohsaka, and T. Sonoki

Copyright © 2013 Zhongchuan W. Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Agency for Research on Cancer and World Health Organization, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer, Lyon, France, 4th edition, 2008.
  2. R. A. Kyle, M. A. Gertz, T. E. Witzig et al., “Review of 1027 patients with newly diagnosed multiple myeloma,” Mayo Clinic Proceedings, vol. 78, no. 1, pp. 21–33, 2003. View at Google Scholar
  3. N. Juge-Morineau, C. Heirman, M. Bakkus et al., “Immunoglobulins D and M multiple myeloma variants are heavily mutated,” Clinical Cancer Research, vol. 3, no. 12, pp. 2501–2506, 1997. View at Google Scholar · View at Scopus
  4. D. E. Reece, D. H. Vesole, S. Shrestha et al., “Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective cibmtr study,” Clinical Lymphoma, Myeloma and Leukemia, vol. 10, no. 6, pp. 458–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. R. Huppmann, M.-L. Liu, and V. E. Nava, “Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow,” Annals of Diagnostic Pathology, vol. 14, no. 4, pp. 268–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Kyle, R. A. Robinson, and J. A. Katzmann, “The clinical aspects of biclonal gammopathies: review of 57 cases,” The American Journal of Medicine, vol. 71, no. 6, pp. 999–1008, 1981. View at Google Scholar · View at Scopus
  7. N. Y. Kim, S. J. Gong, J. Kim, S. M. Youn, and J.-A. Lee, “Multiple myeloma with biclonal gammopathy accompanied by prostate cancer,” Korean Journal of Laboratory Medicine, vol. 31, no. 4, pp. 285–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Franck, N. Petitpain, A. P. Guerci, S. Denisart, C. Jacob, and J. L. Gueant, “Myeloma with two monoclonal IgG and IgD in serum: a case report,” Acta Haematologica, vol. 92, no. 3, pp. 144–147, 1994. View at Google Scholar · View at Scopus
  9. A. M. Tharp, R. D. Woodruff, and Z. K. Shihabi, “IgD-Kappa myeloma: an unusual case,” Annals of Clinical and Laboratory Science, vol. 33, no. 1, pp. 97–100, 2003. View at Google Scholar · View at Scopus
  10. P. Lin, T. J. Molina, J. R. Cook, and S. H. Swerdlow, “Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation,” The American Journal of Clinical Pathology, vol. 136, no. 2, pp. 195–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kriangkum, B. J. Taylor, S. P. Treon et al., “Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences,” Clinical Cancer Research, vol. 13, no. 7, pp. 2005–2013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. D'Angelo, G. Crovetti, N. Grizzetti, and C. Giardini, “Biclonal component in lymphoplasmacytic/lymphoplasmacytoid non-Hodgkin lymphoma,” Recenti Progressi in Medicina, vol. 85, no. 2, pp. 104–107, 1994. View at Google Scholar · View at Scopus
  13. R. Fonseca, E. A. Blood, M. M. Oken et al., “Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients,” Blood, vol. 99, no. 10, pp. 3735–3741, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Avet-Loiseau, R. Garand, L. Lodé, J.-L. Harousseau, and R. Bataille, “Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants,” Blood, vol. 101, no. 4, pp. 1570–1571, 2003. View at Publisher · View at Google Scholar · View at Scopus